Cost-effectiveness of Fosavance® in the treatment and preventation of osteoporosis in the United Kingdom and the Netherlands

被引：0
|
作者：
不详
机构：
来源：
CALCIFIED TISSUE INTERNATIONAL | 2006年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S159 / S159
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of Fosavance® in the treatment and prevention of osteoporosis in the United Kingdom
    Jansen, J.
    Gaugris, S.
    Bergman, G.
    Sen, S. S.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S96 - S96
  • [2] Cost-effectiveness of fosavancet in the treatment of osteoporosis in the Netherlands
    Jansen, J. P.
    Shavit, O.
    Bergman, G.
    Sen, S. S.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S259 - S259
  • [3] Cost-effectiveness of a fixed dose combination of alendronate and cholecalciferol in the treatment and prevention of osteoporosis in the United Kingdom and-The Netherlands
    Jansen, Jeroen P.
    Giaugris, Sabine
    Bergman, Gert
    Sen, Shuvayu S.
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (03) : 671 - 684
  • [4] Cost-effectiveness of human papillomavirus DNA testing in the United Kingdom, The Netherlands, France, and Italy
    Kim, JJ
    Wright, TC
    Goldie, SJ
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (12): : 888 - 895
  • [5] COST-EFFECTIVENESS OF BONT-A PRODUCTS FOR TREATMENT OF PEDIATRIC SPASTICITY IN THE UNITED KINGDOM
    Danchenko, Natalya
    Johnston, Karissa
    Bolatova, Talshyn
    Whalen, John
    TOXICON, 2021, 190 : S15 - S15
  • [6] COST-EFFECTIVENESS OF SCREENING AND TREATMENT OF ALZHEIMER'S DISEASE WITH DONEPEZIL IN THE UNITED KINGDOM
    Getsios, D.
    Blume, S.
    Ishak, K. J.
    MacLaine, G.
    VALUE IN HEALTH, 2009, 12 (03) : A191 - A191
  • [7] Cost-effectiveness of radiofrequency catheter ablation for the treatment of atrial fibrillation in the United Kingdom
    McKenna, C.
    Palmer, S.
    Rodgers, M.
    Chambers, D.
    Hawkins, N.
    Golder, S.
    Van Hout, S.
    Pepper, C.
    Todd, D.
    Woolacott, N.
    HEART, 2009, 95 (07) : 542 - 549
  • [8] COST-EFFECTIVENESS OF BONT-A PRODUCTS FOR TREATMENT OF PEDIATRIC SPASTICITY IN THE UNITED KINGDOM
    Danchenko, N.
    Johnston, K.
    Bolatova, T.
    Whalen, J.
    VALUE IN HEALTH, 2021, 24 : S165 - S166
  • [9] COST-EFFECTIVENESS OF BIOLOGIC THERAPIES FOR THE TREATMENT OF MODERATE TO SEVERE PSORIASIS IN THE UNITED KINGDOM
    Betts, K. A.
    Sundaram, M.
    Mughal, F.
    Yan, S. Y.
    Signorovitch, J.
    Wang, K.
    Wu, E. Q.
    VALUE IN HEALTH, 2013, 16 (07) : A505 - A506
  • [10] Cost-effectiveness of aripiprazole for the management of schizophrenia in the United Kingdom
    Davies, A.
    Vardeva, K.
    Loze, J. Y.
    L'Italien, G. J.
    Sennfalt, K.
    Pugner, K.
    van Baardewijk, M.
    VALUE IN HEALTH, 2008, 11 (03) : A119 - A119
12345